NIH-funded research R01 grant

Identifying the key cells that drive the spread of colorectal cancer

Official title: Towards a complete characterization of the metastasis founder clones in colorectal cancer

Funded at Harvard Medical School · NIH-10867374 · Data updated 2026-11-12

This study is looking at how certain cells in colorectal cancer spread to other parts of the body, using samples from patients to understand the genes that help these cells move around, with the hope of finding better ways to treat the disease.

More Colorectal Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2023
Project endDecember 31, 2028
Funding year2025
Award (this year)$489,231
NIH project number5R01CA269281-03
Project IDNIH-10867374 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with colorectal cancer who are undergoing surgical resection of their tumors.

Less likely to help

Patients with colorectal cancer who are not undergoing surgery or those with advanced metastatic disease may not benefit from this research.

What this research studies

This research investigates how certain cells in colorectal cancer are responsible for metastasis, which is the spread of cancer to other parts of the body. By analyzing samples from patients with colorectal cancer, researchers will look for specific gene expression patterns in these 'metastasis founder clones.' The study involves collecting biopsies from primary tumors and their corresponding metastases, allowing for a detailed examination of the genetic traits that enable these cells to spread. The goal is to create a clearer understanding of how colorectal cancer metastasizes, which could lead to better treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to more targeted therapies that specifically inhibit the spread of colorectal cancer.

How similar studies have gone: Previous research has shown success in identifying metastatic clones in animal models, but this approach in humans is relatively novel and untested.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Naxerova, Kamila — Harvard Medical School
  • Study coordinator: Naxerova, Kamila

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.